Sildenafil Completed Phase 4 Trials for Schizophrenic Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00455715A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia